Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 95% based on the firm’s underlying fundamentals and the stock’s valuation.

Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

Value investors rely on traditional forms of analysis on ... watch right now is Pfizer (PFE). PFE is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock is trading with ...

The stock's fall snapped a four-day winning streak.

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Technical analysis vs SPX500 suggests PFE may be forming ... with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future ...

Below is some historical data on the post-earnings performance of Pfizer stock compared to the stock performance of peers that reported their earnings just before Pfizer. For a fair comparison ...